Rare diseases
Investigational molecules
Locations
Back to Poland1 026 clinical trials in Lodz, Poland across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
PolandA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
PolandStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
PolandA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
PolandA study of navenibart for long-term safety in patients with hereditary angioedema
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandA study testing duvakitug for patients with moderately to severely active ulcerative colitis
PolandA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on respiratory viral infections and preventive vaccines, particularly targeting RSV and influenza in older adults. Studies evaluate vaccine efficacy and immune responses to protect against severe respiratory diseases.
Multiple studies assess combination vaccines and co-administration strategies to enhance protection against multiple respiratory pathogens.
Innovative research examining treatments for plaque psoriasis and related conditions. Trials investigate novel therapeutic approaches including oral medications and biological treatments for moderate to severe cases.
Studies focus on measuring improvement in disease severity and quality of life outcomes for patients.
Comprehensive research on meningococcal and pneumococcal vaccines, with special attention to pediatric populations. Studies evaluate safety profiles and immune responses across different age groups.
Trials incorporate multiple age cohorts from infants to adolescents, ensuring comprehensive vaccine effectiveness data.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
